Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director, Other*
-
Issuer Symbol
-
IRD on Nasdaq
Foundation Fighting Blindness Retinal Degeneration Fund - trading volume in the past year for Opus Genetics, Inc.
Holdings reported by Foundation Fighting Blindness Retinal Degeneration Fund for Opus Genetics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
5,492,171 |
$11,808,167 |
$2.15 |
09 Dec 2025 |
Direct |
|
|
| Series A Non-Voting Convertible Preferred Stock |
0 |
|
|
05 May 2025 |
Direct |
Common Stock |
|
Transactions reported by Foundation Fighting Blindness Retinal Degeneration Fund for Opus Genetics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.